Depression Is Associated with Cognitive Dysfunction in Older Adults with Heart Failure by Garcia, Sarah et al.
Hindawi Publishing Corporation
Cardiovascular Psychiatry and Neurology
Volume 2011, Article ID 368324, 6 pages
doi:10.1155/2011/368324
Clinical Study
DepressionIsAssociatedwithCognitive Dysfunctionin
Older Adults with Heart Failure
SarahGarcia,1 MaryBeth Spitznagel,1,2 Ronald Cohen,3 Naftali Raz,4 LawrenceSweet,3
Lisa Colbert,5 Richard Josephson,6 Joel Hughes,1,2 Jim Rosneck,2 andJohn Gunstad1,2
1Department of Psychology, Kent State University, 221 Kent Hall Addition, Kent, OH 44242, USA
2Department of Psychiatry, Summa Health System, Akron, OH 44304, USA
3Department of Psychiatry and Human Behavior, Brown University, Providence, RI 02912, USA
4Institute of Gerontology, Wayne State University, Detroit, MI 48202, USA
5Department of Kinesiology, University of Wisconsin, Madison, WI 53706, USA
6Harrington-McLaughlin Heart and Vascular Institute, University Hospitals Case Medical Center and
Department of Medicine, Case Western Reserve University School of Medicine, Cleveland, OH 44106, USA
Correspondence should be addressed to John Gunstad, jgunstad@kent.edu
Received 25 August 2011; Revised 15 November 2011; Accepted 18 November 2011
Academic Editor: Gjumrakch Aliev
Copyright © 2011 Sarah Garcia et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Persons with heart failure (HF) frequently exhibit cognitive impairment with deﬁcits in attention and memory. Depression is
common in HF though its possible contribution to cognitive impairment is unknown. Cognitive dysfunction and depression may
share common mechanisms in HF, as both are associated with similar abnormalities on neuroimaging. A total of 116 participants
with HF (68.53 ± 9.30 years) completed a neuropsychological battery and self-report measures of depression. Regression models
showed depression incrementally and independently predicted test performance in all cognitive domains. Follow-up partial
correlations revealed that greater depressive symptoms were associated with poorer performance on tests of attention, executive
function, psychomotor speed, and language. These results indicate that depressive symptoms are associated with poorer cognitive
performance in HF though further work is needed to clarify mechanisms for this association and possible cognitive beneﬁts of
treating depression in persons with HF.
1.Introduction
Heart failure (HF) is prevalent and now aﬀects more than
ﬁve million Americans [1]. Older adults with HF have
high rates of mortality, hospital admissions, and debilitat-
ing symptoms such as shortness of breath, fatigue, and
susceptibility to other medical problems [2]. Though less
frequently examined, mental health issues are common in
persons with HF. Many patients report decline in memory
and other cognitive abilities and an estimated 25% to 75%
of HF patients exhibit impairment on neuropsychological
testing compared to normative data [3]. Deﬁcits emerge
in multiple cognitive abilities, speciﬁcally various types of
memory [4, 5]. Executive functions such as attention and
problem solving are also impaired. Similarly, depression
is also common in persons with HF [6]. Though rates
vary across studies, an estimated 21%–36% of heart failure
patients can be diagnosed with depression, on the basis
of both clinical diagnoses and elevated rates on various
depression questionnaires [7, 8].
Few studies have directly examined the association
between cognitive impairment and depression in persons
with HF despite the likelihood of common mechanisms. For
example, persons with HF exhibit numerous pathological
changes on neuroimaging, including greater atrophy and
the presence of white matter hyperintensities, frequently
in frontal brain regions [9]. In turn, these changes are
associated with increased depressive symptoms in healthy
olderadultsandotherpatientsamples[10,11].Suchﬁndings
suggest that depression is closely associated with cognitive
impairment in persons with HF, and we examined this
possibilityinasampleofwell-characterizedolderadultswith2 Cardiovascular Psychiatry and Neurology
Table 1: Demographic, medical, and cognitive characteristics of
116 older adults with HF.
Demographic Mean (SD) Percent
Age 68.53 (9.30)
Female 36.5
Hypertension 70
Heart attack 55.4
Type 2 diabetes 34.1
CABG/bypass surgery 35.2
2-min step test 59.58 (22.90)
Depression Mean (SD) Percent impaired
BDI 8.20 (7.66) 19
Cognitive function Mean (SD) Percent impaired
3MS 92.50 (5.72) 11
TMT-A 43.07 (18.70) 9.7
TMT-B 114.69 (56.43) 3.9
FAB 15.59 (2.56) 9.4
Digit Symbol 49.34 (14.93) 4.1
CVLT 38.67 (11.29) 4.1
CFT 25.35 (5.89) 7.1
BNT-II 53.63 (5.96) 8.3
Animal Naming 19.01 (4.90) 2.9
Pegboard 102.83 (25.33) 6.6
HF. To further elucidate possible mechanisms for their co-
occurrence, results from transcranial doppler (TCD) were
also examined.
2. Methods
2.1. Participants. One hundred and sixteen adults diagnosed
with HF were recruited from Summa Health System for
this study (68.53 ± 9.30 years; 36.5% female). See Table 1.
For inclusion, participants were between the ages of 50–
85 years of age, English-speaking, and had an established
diagnosis of New York Heart Association (NYHA) class II
or IIIHF at the time of enrollment. Potential participants
were excluded for history of signiﬁcant neurological disorder
(e.g., dementia and stroke), head injury with more than 10
minutes loss of consciousness, severe psychiatric disorder
(e.g., schizophrenia and bipolar disorder), substance use,
renal failure, and sleep apnea.
2.2. Instrumentation
2.2.1. Neuropsychological Tests. Participants were admin-
istered a neuropsychological battery by trained research
personnel under the supervision of a licensed clinical
neuropsychologist to assess the following cognitive domains.
Global Cognitive Function. The modiﬁed minimental state
examination (3MS) is brief screening measure that provides
an estimate of global cognitive function through attention,
memory, language, and spatial abilities [12]. A lower score
on the test indicates poorer cognition.
Attention and Executive Function. Attention and executive
function were assessed using the frontal assessment battery
(FAB), the trail making test A (TMT-A), the trail making
test B (TMT-B), and the symbol digit modalities test. The
FAB is a short measure consisting of six subtests that
assess aspects of executive function. Subtests include brief
versions of similarities, lexical ﬂuency, motor series task
of attention, and tasks of motor inhibition. Higher scores
reﬂect better performance [13]. Both the TMT-A and TMT-
B ask participants to rapidly draw a connecting line between
numbered circles (TMT-A) or alternating numbered and
lettered circles (TMT-B) [12]. Longer completion time is
indicative of worse cognitive performance. The symbol digit
modalities test is a reliable and valid measure of visuomotor
speed and complex attention [14]. The task requires speeded
coding of numbers to correspond with symbols and lower
scores illustrate worse performance.
Memory. The California verbal learning test-second edition
(CVLT) and the complex ﬁgure test (CFT) were used to
measure memory. The CVLT requires learning, recall, and
recognition of a 16-item word list. This test incorporates
indices of learning (sum of trials 1–5), immediate recall
(short free recall), delayed recall (long free recall), and
recognition (discrimination) [15]. For analyses these four
scores were averaged into one overall CVLT score. The CFT
requires copying, a short delay recall, and a long delay recall
of a complex geometric design [16]. Again, both the short
delay recall and long delay recall scores were averaged to
create one overall CFT score. For both the CVLT and CFT
higher scores indicate better performance.
Language. To measure language, the Boston naming test-
II (BNT-II) and the Animal naming task were used. The
BNT-II consists of 60 illustrations of objects ranging from
high familiarity to low and asks individuals to name each
object pictured [12]. Animal Naming asks individuals to
generate as many animal names as possible within a given
time limit [17]. Lower scores on both tests indicate poorer
performance.
Motor. The grooved pegboard was used to measure complex
coordination and speeded ﬁne motor skill [12]. Individuals
place notched pegs into a 5 × 5 board as quickly as possible.
Time to completion for dominant and nondominant hand
performance is recorded, and shorter duration represented
better motor skills.
2.2.2. Depressive Symptoms. The Beck depression inventory
II (BDI-II) was used to measure the presence and severity of
depression [18]. This measure is a 21-item self-report instru-
ment and has good psychometric properties. Higher scores
on the BDI-II indicate more severe depressive symptoms.
2.2.3. Cardiovascular Fitness. To estimate current level of
cardiac ﬁtness, all participants completed the two minute
step test (2MST) [19]. The test asks individuals to walk in
place, lifting their knees to a target midway between theirCardiovascular Psychiatry and Neurology 3
kneecap and the crest of the iliac. Participants were able to
use a wall or chair for balance. A higher step count indicates
better cardiovascular ﬁtness.
2.2.4. Cerebral Blood Flow. Transcranial doppler (TCD) was
used to measure cerebral blood ﬂow. After head mea-
surements, participants completed a 10-minute rest period
before an expanded STOP protocol was conducted [20].
Mean velocity and pulsatility was calculated for both the
anterior cerebral arteries (ACA-V and ACA-P) and middle
cerebral arteries (MCA-V and MCA-P).
2.3. Procedure. All procedures were approved by the local
Institutional Review Board and participants provided writ-
ten consent before enrollment. Participants ﬁrst completed
a 90-minute neuropsychological battery by trained research
personnel under the supervision of a licensed clinical neu-
ropsychologist in order to assess multiple cognitive functions
as well as a 2-minute step test to evaluate cardiac ﬁtness.
A series of demographic, medical history, and self-report
questionnaires, including the BDI-II, were then completed
by all participants. Finally, participants completed the TCD
evaluation within 2 weeks of this primary evaluation.
2.4. Data Analysis. In order to compare across tests, raw
scores were converted to T-scores using established nor-
mative data. Impairment for each test was operationalized
as being >1.5 standard deviations below normative perfor-
mance. Frontal, memory, and language composite scores
were calculated by averaging the T-scores of neuropsy-
chological tests on the basis of their respective composite
category. Speciﬁcally, (1) the frontal composite score was
comprised of the FAB, TMT-A, TMT-B, and the symbol digit
modalities test, (2) the memory composite score was made
up of the CVLT and CFT, and (3) the language composite
score incorporated the BNT-II and the animal naming task.
The motor functioning comprehensive score only used the
pegboard task, whereas the global function category only
comprised the 3MS.
Separate linear regression models were preformed for
each composite score as well as motor function and global
cognitivefunctioning.Regressionanalyseswereconductedin
block format to determine whether depression was indepen-
dently associated with cognitive test performance. The ﬁrst
block included demographic and medical control variables,
speciﬁcally sex, hypertension, and cardiac ﬁtness. BDI scores
were then entered in the second block, and incremental
prediction of the model to predict cognitive performance
was examined. Finally, partial correlations adjusting for sex,
hypertension, and cardiac ﬁtness (2MST) were then con-
ducted between depression and each individual neuropsy-
chological test as well as TCD results to clarify regression
ﬁndings. SPSS version 19 was utilized for all study analyses.
3. Results
3.1. Prevalence of Cognitive Impairment and Depressive Symp-
tomatology. Patients demonstrated cognitive impairment on
all neuropsychological tests. See Table 1. Approximately 19%
of participants had an elevated score of 14 or more on the
BDI-II, indicating clinically signiﬁcant levels of depression
[21].
3.2. Depression Is a Predictor of Cognitive Impairment in HF.
Regressions were conducted between depression and the
compositescoresofeachcognitivedomainafteradjustingfor
sex, hypertension, and cardiac ﬁtness (62.39 ± 22.08 steps).
RegressionanalysesshowedBDIscoresprovidedincremental
prediction for all composite scores after adjusting for control
variables, including global cognitive functioning (F(4,143) =
8.09,ΔR2 <. 001,P<0.001),attention/executive(F(4,143) =
12.41, ΔR2 = .03, P<0.001), memory composite scores
(F(4,143) = 3.04, ΔR2 = .03, P = 0.02), language composite
scores (F(4,143) = 7.20, ΔR2 = .03, P<0.001), and motor
functioning (F(4,126) = 11.01, ΔR2 = .03, P<0.001). See
Table 2.
3.3. Frontal, Language, and Motor Impairment in HF. To
clarify these ﬁndings, partial correlations adjusting for sex,
hypertension, and cardiac ﬁtness between the BDI-II and
speciﬁc neuropsychological test scores and TCD results were
computed. Results showed multiple signiﬁcant correlations
between the BDI and cognitive test performance, including
trail making test A (r =− .20, P = 0.04), trail making test
B( r =− .32, P<0.01), digit symbol coding (r =− .25,
P = 0.01), grooved pegboard (r =− .21, P = 0.02), and
the Boston naming test (r =− .25, P<0.01). A trend was
noted for animal naming (r =− .18, P = 0.05). There were
no signiﬁcant partial correlations between depression and
3MS, FAB, CVLT, and CFT or for the association between
depression and TCD indices. See Table 3.
4. Discussion
Findingsfromthecurrentstudydemonstratethatdepression
is independently associated with multiple tests of cognitive
function in older adults with HF, including measures of
attention, executive function, and language abilities. No such
pattern emerged for tests of learning and memory. Several
aspects of these ﬁndings warrant brief discussion.
The prevalence of cognitive impairment within our
sample is higher than that of healthy older adults and
broadly consistent with past research in persons with HF
[5]. Participants exhibited deﬁcits on all cognitive tests,
especially frontal and motor tasks. Cognitive deﬁcits within
this population often impact daily living and increase
mortality [3, 22]. For example, recent work indicates that
cognitive dysfunction is associated with reduced ability to
complete activities of daily living in persons with HF [23].
Similarly, the current results also indicated a large number of
participants to have clinically signiﬁcant levels of depressive
symptoms.Aswithcognitiveimpairment,depressionconfers
many additional risks and is associated with poor outcomes
in HF patients, including reduced compliance with medical
regimen, higher risk for readmission, and greater mortality4 Cardiovascular Psychiatry and Neurology
Table 2: Linear regressions between depression and cognitive composite scores.
Variable B SE β tP ΔR2
Frontal composite
Control variables .16 .03 .42 5.66 <0.001 .23
Full model −.17 .08 −.17 −2.28 0.02 .03
Memory composite
Control variables .07 .03 .19 2.36 0.02 .07
Full model −.12 .08 −.12 −1.50 0.14 .01
Language composite
Control variables .12 .03 .32 4.08 <0.001 .14
Full model −.18 .08 −.17 −2.23 0.03 .03
Motor function
Control variables .20 .04 .43 5.38 <0.001 .23
Full model −.25 .10 −.19 −2.43 0.02 .03
Global cognitive
Control variables .17 .03 .39 5.06 <0.001 .18
Full model −.03 .10 −.02 −.26 0.78 <.001
Control variables included sex, hypertension, and cardiac ﬁtness.
Table 3: Partial correlations among BDI, TCD results, and test
performance.
Variable rP
Cognitive tests
Global cognitive function
3MS .02 0.86
Attention and executive function
TMT-A −.20 0.04∗
TMT-B −.32 <0.01∗∗
FAB −.13 0.18
Digit symbol −.25 0.01∗
Memory
CVLT −.14 0.15
CFT −.10 0.31
Language
BNT-II −.25 <0.01∗∗
Animal naming −.18 0.05
Motor
Pegboard −.21 0.02∗
Transcranial Doppler
MCA-pulsatility −.01 0.88
MCA-mean velocity −.11 0.25
ACA-pulsatility .04 0.71
ACA-mean velocity −.14 0.14
∗P<0.05. ∗∗P<0.01. All correlations adjusted for sex, hypertension, and
cardiac ﬁtness.
risk [24, 25]. Given the projected increase in HF preva-
lence, further work is much needed to develop improved
treatmentsoptionsandcompensatorystrategiesforcognitive
impairment and depression in persons with HF [26].
Self-reported depressive symptoms on the BDI-II were
independently associated with performance on all cognitive
domains in this sample of older adults with HF not just
tests of attention and executive function. Past work had
shown that persons with major depressive disorder exhibit
impairments on tests of attention, executive function, and
visuospatial learning and older adults with depression show
reductions on executive function and memory [27, 28]. The
current results extend this work and suggest that depression
is associated with reduced performance on global and
speciﬁc measures of cognitive function in persons with HF.
Several possible explanations for these ﬁndings exist,
including the known impact of depression on speeded
tasks such as the trail making test and motor performance
[29]. However, a possible, alternative explanation is that
depression exhibited by HF patients may be at least partly
duetostructuralbrainchanges[24,30].Bothdepressionand
cognitive processes, such as speeded tasks, may be aﬀected
by structural brain changes resulting from cardiovascular
disease, similar to other medical illnesses [11, 31]. For
example, disruption in frontal-striatal pathways is associated
with reduced function on tests of executive functioning
and also with depressive symptoms in older adults [32–
34]. Such ﬁndings may account for the poor success rates
in traditional interventions for depression when used in
p e r s o n sw i t hH F[ 35, 36], as it is possible that the depression
in such samples is not an emotional reaction but rather
a neuropsychiatric condition that emerges secondary to
structural brain changes. Prospective studies that examine
depression, cognitive function, and neuroimaging are much
needed to clarify this possibility.
An interesting ﬁnding from the current study is that
while depression was associated with frontal/subcortical
tasks, it was also strongly correlated with the BNT-II, a lan-
guage task predominately mediated by temporal lobe func-
tioning. Trends from another language-based task, animal
naming, further support the association between depression
and language functioning in persons with HF. One possible
explanation for this pattern involves the possible damage
to frontal-striatal pathways found in HF noted above, asCardiovascular Psychiatry and Neurology 5
past studies have linked reduced frontal functioning to
poorer language function [37]. Given the age and medical
characteristics of the current sample, this association may
also reﬂect the contribution of early Alzheimer’s disease
(AD). Deﬁcits in confrontation naming are often among the
ﬁrst deﬁcits in persons with early stage AD, and the BNT-II is
known to be sensitive to these deﬁcits [38]. Additional work
is much needed to better understand the possible association
between depression and AD pathology in persons with HF.
In brief summary, depression is correlated with cog-
nitive impairment in HF patients, and future research is
neededtoclarifypossiblemechanisms,includingthepossible
contribution of abnormalities on neuroimaging. A better
understanding of the association between depression and
cognitive impairment may improve treatment outcomes
for HF patients. Medical professionals should be aware of
the possible relationship between depression and cognitive
function in HF, as the current ﬁndings suggest a high rate
of co-occurrence. Care providers detecting one condition
are encouraged to also screen for the other. Future studies
are needed to clarify the possible eﬀectiveness of screening
for depression and cognitive function in persons with HF
in reducing hospitalization and mortality rates. Such studies
could reduce the high personal and ﬁnancial burden of HF.
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